Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characteristics and Outcomes of COVID-19 Patients in New York City's Public Hospital System.
Kalyanaraman Marcello R, Dolle J, Grami S, Adule R, Li Z, Tatem K, Anyaogu C, Ayinla R, Boma N, Brady T, Cosme-Thormann BF, Ford K, Gaither K, Kanter M, Kessler S, Kristal RB, Lieber JJ, Mukherjee V, Rizzo V, Rowell M, Stevens D, Sydney E, Wallach A, Chokshi DA, Davis N. Kalyanaraman Marcello R, et al. Among authors: ayinla r. medRxiv [Preprint]. 2020 Jun 23:2020.05.29.20086645. doi: 10.1101/2020.05.29.20086645. medRxiv. 2020. Update in: PLoS One. 2020 Dec 17;15(12):e0243027. doi: 10.1371/journal.pone.0243027 PMID: 32577680 Free PMC article. Updated. Preprint.
Characteristics and outcomes of COVID-19 patients in New York City's public hospital system.
Kalyanaraman Marcello R, Dolle J, Grami S, Adule R, Li Z, Tatem K, Anyaogu C, Apfelroth S, Ayinla R, Boma N, Brady T, Cosme-Thormann BF, Costarella R, Ford K, Gaither K, Jacobson J, Kanter M, Kessler S, Kristal RB, Lieber JJ, Mukherjee V, Rizzo V Jr, Rowell M, Stevens D, Sydney E, Wallach A, Chokshi DA, Davis N; New York City Health + Hospitals COVID-19 Population Health Data Team. Kalyanaraman Marcello R, et al. Among authors: ayinla r. PLoS One. 2020 Dec 17;15(12):e0243027. doi: 10.1371/journal.pone.0243027. eCollection 2020. PLoS One. 2020. PMID: 33332356 Free PMC article.
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
Portal-Celhay C, Forleo-Neto E, Eagan W, Musser BJ, Davis JD, Turner KC, Norton T, Hooper AT, Hamilton JD, Pan C, Mahmood A, Baum A, Kyratsous CA, Kim Y, Parrino J, Kampman W, Roque-Guerrero L, Stoici R, Fatakia A, Soo Y, Geba GP, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman GA, Yancopoulos GD, Weinreich DM; COVID-19 Phase 2 Dose-Ranging Study Team. Portal-Celhay C, et al. JAMA Netw Open. 2022 Aug 1;5(8):e2225411. doi: 10.1001/jamanetworkopen.2022.25411. JAMA Netw Open. 2022. PMID: 35969402 Free PMC article. Clinical Trial.
Barriers to activation of the rapid response system.
Davies O, DeVita MA, Ayinla R, Perez X. Davies O, et al. Among authors: ayinla r. Resuscitation. 2014 Nov;85(11):1557-61. doi: 10.1016/j.resuscitation.2014.07.013. Epub 2014 Aug 7. Resuscitation. 2014. PMID: 25108061
Computer access of morning report/ Harrison Club PowerPoint presentations to the medicine residents has improved their confidence in management and in preparation for the monthly exams and for the American Board of Internal Medicine: an innovative education quality improvement project at Harlem Hospital center.
Osman M, Tijani S, Fagir M, Ayinla R. Osman M, et al. Among authors: ayinla r. J Community Hosp Intern Med Perspect. 2020 Feb 10;10(1):6-9. doi: 10.1080/20009666.2019.1710947. eCollection 2020. J Community Hosp Intern Med Perspect. 2020. PMID: 32128051 Free PMC article.
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, Aazami H, Cannon K, Simón-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. Weinreich DM, et al. N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29. N Engl J Med. 2021. PMID: 34587383 Free PMC article. Clinical Trial.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939. JAMA. 2022. PMID: 35029629 Free PMC article. Clinical Trial.
20 results